OCA Announces Decent 1HY2019 Results

OCA Announces Decent 1HY2019 Results

Oceania Healthcare Limited (ASX: OCA) announces its half-yearly results to the market (6 months to 30 November 2018). The underlying NPAT was 5.3% above 1HY2018 and there is 8.7% growth in continuing operations as compared to 1HY2018. OCA is a care focused operator and developer of aged care homes and retirement villages. 

The village segment saw a resale and development margins were in line with FY2018 and remained at strong levels.  The gains on resale decreased due to lower volumes of ILUs sold (32in 1HY2019 v 44 in 1HY2018). However, resales margins for ILUs (Independent level unit) were consistent at 30.3% in 1HY2019. The total sales of 114 units and care suites in 1HY2019 is 56.5% higher than the 92 achieved in 1HY2018.

The total comprehensive income for the period of $19.5m reflects the delivery of the new care suites at the Bay View and gains in valuation in relation to their premium care suites. Their operating revenue increased by 4.7 % with revenue up by 3.7% to $82.9m and village DMF up by 14.3% to $18.9m. The care suites were also revalued. The fair value of these increased by a $18.2m net of tax, reflected in Other Comprehensive Income. The operating expenses increased due to higher care wages following the equal pay settlement for HCA’s and 5% increase provided to the RNs ($3.7m in total) as well as the rental payment for the right to use asset at Everil Orr ($4.8m).

The total assets of the company increased by $209.7m (21%) from 1HY2018. The capital expenditure has almost doubled to 95.3m in 1HY2019 from $49.2in 1HY2018. The Net Adjusted Value (NAV) is recorded at $1.06 per share as at 1HY2019. The operating cash flows of $47.1m for 1HY2019 were materially ahead of the $17.1m in 1HY2018, reflecting the sell down of new developments.

All the sixty- two apartments at Meadowbank Stage 3 delivered in January 2018 are sold or are under application. A total number of 81 suites have been completed at The Bay View (on time and on forecast cost). They are on track to deliver their increased build rate of 250 units and care suits per annum to 2020 and more than 300 per annum post that. There is a robust performance in the village segment, maintaining a resale margin of 30.3 % for villas and apartments; in line with the margin for FY2018. There was also progress in executing their aged care strategy which continued with strong MoH (Ministry of Health) audit results with 31% of homes at four years, all others at 3 years (up from 25% at 4 years as at 1HY2018). The company declared their interim dividend per share as 2.10 cents per share (not imputed).

The gearing level in the capital structure has increased from 18.7% to 26.6% in the period as they have drawn down to fund their developments.

The shares of OCA closed the day’s session at A$1.020, down by 0.971 % or 0.010 points as compared to the last day close of A$1.030 (as on 25 January 2019).


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Top 25 Dividend Stocks report for April

People prefer a dividend stock in their portfolio as it possesses the feature of compounding. Compounding means that the earning which is generated through these dividend stock will get reinvested and will eventually create earnings from earning. More precisely, the dividend generated from these dividend stock will get reinvested to buy another set of a share of the dividend stock which results in giving a higher dividend.

Click here to download your top 25 dividend stocks report!

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report